½ÃÀ庸°í¼­
»óǰÄÚµå
1713246

°æÀ念¾ç ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2021-2031³â), ¼¼°è ¹× Áö¿ª Á¡À¯À², µ¿Çâ, ¼ºÀå ±âȸ ºÐ¼® : Á¦Ç° À¯Çüº°, ¿ëµµº°, ¿¬·ÉÃþº°, À¯Åë ä³Îº°, Áö¿ªº°

Enteral Nutrition Market Size and Forecast 2021 - 2031, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type, Application, Age Group, Distribution Channel, and Geography

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: The Insight Partners | ÆäÀÌÁö Á¤º¸: ¿µ¹® 281 Pages | ¹è¼Û¾È³» : Áï½Ã¹è¼Û

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

°æÀ念¾ç ½ÃÀåÀº 2024³â¿¡ 105¾ï 8,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾úÀ¸¸ç 2031³â±îÁö 173¾ï 3,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2025-2031³â »çÀÌ 7.3%ÀÇ CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. À§Àå ÁúȯÀÇ À¯º´·ü Áõ°¡, ¿µ¾ç½ÇÁ¶ ¹× Á¶»ê »ç·ÊÀÇ Áõ°¡´Â °æÀ念¾ç ½ÃÀå ±Ô¸ð È®´ë¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ±×·¯³ª ¿µ¾ç °ø±Þ ½Ã½ºÅÛ¿¡ µû¸¥ ÇÕº´ÁõÀº Àå³» ¿µ¾ç ½ÃÀåÀÇ ¼ºÀåÀ» ÀúÇØÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ½Ä¹° ±â¹Ý ¿µ¾ç Á¦Ç°ÀÇ °³¹ßÀº ÇâÈÄ ¸î ³â µ¿¾È »õ·Î¿î Àå³» ¿µ¾ç ½ÃÀå µ¿ÇâÀ» °¡Á®¿Ã °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¾Æ½Ã¾ÆÅÂÆò¾çÀº Àü ¼¼°è °æÀ念¾çÁ¦ ½ÃÀå¿¡¼­ °¡Àå ºü¸¥ ¼ºÀå·üÀ» º¸À̰í ÀÖ½À´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ °æÀ念¾ç½Ä ½ÃÀåÀº Áß±¹, ÀϺ», Àεµ, Çѱ¹, È£ÁÖ, ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾çÀ¸·Î ±¸ºÐµË´Ï´Ù. ÀÌ ½ÃÀåÀÇ ¼ºÀåÀ» ÁÖµµÇϰí ÀÖ´Â °ÍÀº ¸¸¼ºÁúȯÀÇ À¯º´·ü Áõ°¡¿Í ÀÌ Áö¿ª Àüü¿¡¼­ ½ÃÀå ÁøÀÔ ±â¾÷ÀÇ Á¸Àç°¨ÀÌ Áõ°¡Çϰí ÀÖÀ¸¸ç, °æÀ念¾ç Á¦Ç° Á¦Á¶°¡ °¡Àå Ȱ¹ßÇÏ°Ô ÀÌ·ç¾îÁö°í ÀÖ´Ù´Â °ÍÀ» ¾Ë ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Á¤ºÎÀÇ Àû±ØÀûÀÎ ³ë·Â°ú ¿µ¾ç ºÐ¾ßÀÇ ¿¬±¸°¡ ½ÃÀå ¼ºÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. È£ÁÖ, Àεµ, Çѱ¹ µîÀÇ ±¹°¡´Â ÀÇ·á ºÎ¹®ÀÇ ¹ßÀüÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ´Ù¾çÇÑ ¼ºÀå ±âȸ¸¦ º¸ÀÏ °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù. ¶ÇÇÑ, ÀÌµé ±¹°¡ÀÇ Á¤ºÎ´Â °æÀå ¹× ºñ°æ±¸ ¿µ¾ç °ø±ÞÀ» À§ÇÑ ³ë·ÂÀ» °­È­Çϰí ÀÖ½À´Ï´Ù.

¼öÀÍ Ãø¸é¿¡¼­´Â Áß±¹ÀÌ 2024³â ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀåÀ» Àå¾ÇÇß½À´Ï´Ù. ¿¹Ãø ±â°£ µ¿¾È ¼¼°è ½ÃÀå¿¡¼­ Áß±¹ÀÇ ¿ìÀ§´Â °è¼ÓµÉ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

Áß±¹¿¡¼­´Â ³ëÀÎ Àα¸°¡ Å©°Ô Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ±Þ¼ÓÇÑ °í·ÉÈ­·Î ÀÎÇØ ¸¸¼ºÁúȯÀÇ À¯º´·üÀÌ Áõ°¡ÇÏ°í ¿µ¾ç Áö¿øÀÌ ÇÊ¿äÇѵ¥, 2020³â Àα¸ Á¶»ç µ¥ÀÌÅÍ¿¡ µû¸£¸é ¾à 2¾ï 6,400¸¸ ¸íÀÌ 60¼¼ ÀÌ»ó ¿¬·ÉÃþÀ¸·Î Áß±¹ Àα¸ÀÇ ¾à 19%¸¦ Â÷ÁöÇÕ´Ï´Ù. Áß±¹ ±¹°¡°í·ÉÈ­À§¿øÈ¸(CNCA)´Â 2050³â±îÁö ³ëÀÎ Àα¸°¡ ¾à 4¾ï 8,700¸¸ ¸í¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøÇϰí ÀÖ½À´Ï´Ù. ³ëÀÎ Àα¸ÀÇ Áõ°¡¿¡ µû¸¥ ½Å°æ ÁúȯÀÇ À¯º´·ü Áõ°¡´Â Áß±¹ ³» °æÀ念¾ç äÅÃÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ³úÁ¹ÁßÀº Áß±¹ ³ëÀÎÀÇ ÁÖ¿ä »ç¸Á ¿øÀÎÀ¸·Î, ¿¤½ººñ¾î(Elsevier)¿¡ °ÔÀçµÈ ¿¬±¸¿¡ µû¸£¸é 2020³â Áß±¹¿¡¼­´Â 1,780¸¸ °ÇÀÇ ³úÁ¹Áß, 340¸¸ °ÇÀÇ ½Å±Ô ³úÁ¹Áß, 230¸¸ °ÇÀÇ ³úÁ¹Áß °ü·Ã »ç¸ÁÀÌ º¸°íµÇ¾ú½À´Ï´Ù. ³úÁ¹ÁßÀº ±Þ¼º ¿¬ÇÏÀå¾ÖÀÇ °¡Àå ÈçÇÑ ¿øÀÎÀ¸·Î ¿µ¾ç½ÇÁ¶¸¦ À¯¹ßÇϰí ȯÀÚÀÇ »îÀÇ Áú¿¡ ¿µÇâÀ» ¹ÌÄ¥ ¼ö ÀÖ½À´Ï´Ù. Áß±¹¿¡¼­´Â ÁßÁõ ³úÁ¹Áß È¯ÀÚÀÇ ¿µ¾ç °³¼± Àü·«À¸·Î °æ°ü¿µ¾çÀÌ ½ÃÇàµÇ°í ÀÖ½À´Ï´Ù.

WHO¿¡ µû¸£¸é 2022³â Áß±¹¿¡¼­´Â 480¸¸ ¸íÀÇ ¾Ï ȯÀÚ°¡ »õ·Î ¹ß»ýÇϰí 250¸¸ ¸íÀÌ ¾ÏÀ¸·Î »ç¸ÁÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ¸ÅºÐ 7¸í °¡±îÀÌ ¾Ï Áø´ÜÀ» ¹Þ°í 4¸íÀÌ ¾ÏÀ¸·Î »ç¸ÁÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¸ÅºÐ 7¸íÀÌ ¾Ï Áø´ÜÀ» ¹Þ°í 4¸íÀÌ ¾ÏÀ¸·Î ¸ñ¼ûÀ» ÀÒ°í ÀÖ½À´Ï´Ù. °æÀ念¾çÁ¦ÀÇ »ç¿ëÀº È­Çпä¹ýÀ» ¹Þ°í ÀÖ´Â ¾Ï ȯÀÚ¿¡¼­ ÈçÈ÷ º¼ ¼ö ÀÖÀ¸¸ç, ¸Þ½º²¨¿ò, ±¸³»¿°, À§ÀåÀå¾Ö·Î ÀÎÇØ ½Ä»ç¿¡ ¾î·Á¿òÀ» °Þ´Â °æ¿ì°¡ ¸¹½À´Ï´Ù.

Àå³» ¿µ¾ç ½ÃÀå º¸°í¼­ ºÎ¹® ºÐ¼®

Àå³» ¿µ¾ç ½ÃÀå ºÐ¼® µµÃâ¿¡ ±â¿©ÇÑ ÁÖ¿ä ºÎ¹®Àº Á¦Ç° À¯Çü, ¿ëµµ, ¿¬·É´ë, À¯Åë ä³ÎÀÔ´Ï´Ù.

Á¦Ç° À¯Çü¿¡ µû¶ó °æÀ念¾ç ½ÃÀåÀº ºñÀ§°ü, ºñÀ§°ü, °æÀå, ¹è¼Û, ±âŸ·Î ºÐ·ùµÇ¸ç, 2024³â °æÀ念¾ç ½ÃÀåÀº ºñÀ§°ü ºÎ¹®ÀÌ °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¿ëµµº°·Î´Â ¼ÒÈ­±â Áúȯ, ½ÅÀå Áúȯ, °£ Áúȯ, Á¾¾çÇÐ, ½Å°æÇÐ, ±âŸ·Î ºÐ·ùµÇ¸ç, 2024³â °æÀ念¾çÁ¦ ½ÃÀåÀº ¼ÒÈ­±â Áúȯ ºÐ¾ß°¡ °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¿¬·É´ëº°·Î Àå³» ¿µ¾ç ½ÃÀåÀº ¼ºÀΰú ¼Ò¾Æ·Î ³ª´¹´Ï´Ù. ¼ºÀÎ ºÎ¹®Àº 2024³â °æÀ念¾çÁ¦ ½ÃÀå¿¡¼­ °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.

À¯Åë ä³Î¿¡ µû¶ó °æÀ念¾ç ½ÃÀåÀº º´¿ø ¾à±¹, ¼Ò¸ÅÁ¡, E-Commerce·Î ±¸ºÐµÇ¸ç, 2024³â °æÀ念¾ç ½ÃÀåÀº º´¿ø ¾à±¹ ºÎ¹®ÀÌ °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Àå³» ¿µ¾ç ½ÃÀå °æÀï »óȲ ¹× ÁÖ¿ä ¹ßÀü »óȲ

Nestle,Danone S.A.,Abbott Laboratories,FrieslandCampina,Fresenius SE and Co.KGaA,B. Braun SE,Dr. Company PLC, Fonterra Co-operative Group Limited, Kate Farms, Nutritional Medicinals, LLC µîÀÌ °æÀ念¾çÁ¦ ½ÃÀå¿¡¼­ »ç¾÷À» Àü°³ÇÏ´Â ÁÖ¿ä ±â¾÷ÀÔ´Ï´Ù.

±¹¹Îº¸°Ç¼­ºñ½º(NHS), ¿µ±¹ ºñ°æ±¸ ¹× °æÀ念¾çÇùȸ, ¼¼°èº¸°Ç±â±¸(WHO), ¹Ì±¹ º¸°Çº¹ÁöºÎ, Áúº´ÅëÁ¦¿¹¹æ¼¾ÅÍ, ¿µ±¹¿µ¾ç»çÇùȸ, ±¹°¡¾ÈÀüÀ§¿øÈ¸ µîÀº °æÀ念¾ç ½ÃÀå º¸°í¼­¸¦ ÀÛ¼ºÇÒ ¶§ Âü°íÇÑ 1Â÷ ¹× 2Â÷ Á¤º¸ÀÔ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼Ò°³

Á¦2Àå ÁÖ¿ä ¿ä¾à

  • ÁÖ¿ä ÀλçÀÌÆ®

Á¦3Àå Á¶»ç ¹æ¹ý

  • 2Â÷ Á¶»ç
  • 1Â÷ Á¶»ç
    • °¡¼³ Ã¥Á¤
    • °Å½Ã°æÁ¦ ¿äÀÎ ºÐ¼®
    • ÆÄ¿îµ¥ÀÌ¼Ç ¼öÄ¡ °³¹ß
    • µ¥ÀÌÅÍ »ï°¢Ãø·®
    • ±¹°¡ ·¹º§ µ¥ÀÌÅÍ

Á¦4Àå °æÀ念¾ç ½ÃÀå »óȲ

  • PEST ºÐ¼®

Á¦5Àå °æÀ念¾ç ½ÃÀå - ÁÖ¿ä ½ÃÀå ¿ªÇÐ

  • °æÀ念¾ç ½ÃÀå - ÁÖ¿ä ½ÃÀå ¿ªÇÐ
  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • À§ÀåÁúȯ À¯º´·ü Áõ°¡
    • ¿µ¾ç ºÒ·®°ú Á¶»ê ÄÉÀ̽º Áõ°¡
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ¿µ¾ç º¸±Þ ½Ã½ºÅÛ¿¡ µû¸¥ ÇÕº´Áõ
  • ½ÃÀå ±âȸ
    • ½ÃÀå ±â¾÷ÀÇ Àü·«Àû ´ëó
  • ÇâÈÄ µ¿Çâ
    • ƯÁ¤ 󹿰ú ½Ä¹° ±â¹Ý ¿µ¾ç Á¦Ç°
  • ¼ºÀå ÃËÁø¿äÀΰú ¾ïÁ¦¿äÀÎÀÇ ¿µÇâ

Á¦6Àå °æÀ念¾ç ½ÃÀå : ¼¼°è ½ÃÀå ºÐ¼®

  • °æÀ念¾ç ½ÃÀå ¸ÅÃâ, 2021-2031³â
  • °æÀ念¾ç ½ÃÀå ¿¹Ãø ºÐ¼®

Á¦7Àå °æÀ念¾ç ½ÃÀå ºÐ¼® - Á¦Ç° À¯Çüº°

  • Nasogastric
  • Nasoenteral
  • Sipping
  • ±âŸ

Á¦8Àå °æÀ念¾ç ½ÃÀå ºÐ¼® - ¿ëµµº°

  • ¼ÒÈ­±âÁúȯ
  • ½ÅÀåÁúȯ
  • °£Áúȯ
  • Á¾¾çÇÐ
  • ½Å°æÇÐ
  • ±âŸ

Á¦9Àå °æÀ念¾ç ½ÃÀå ºÐ¼® - ¿¬·ÉÃþº°

  • ¼ºÀÎ
  • ¼Ò¾Æ

Á¦10Àå °æÀ念¾ç ½ÃÀå ºÐ¼® - À¯Åë ä³Îº°

  • º´¿ø ¾à±¹
  • ¼Ò¸ÅÁ¡
  • E-Commerce

Á¦11Àå °æÀ念¾ç ½ÃÀå - Áö¿ªº° ºÐ¼®

  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´
    • µ¶ÀÏ
    • ¿µ±¹
    • ÇÁ¶û½º
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • üÄÚ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • ÀϺ»
    • Àεµ
    • Çѱ¹
    • È£ÁÖ
    • ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ±âŸ ±¹°¡
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • ¾Æ¶ø¿¡¹Ì¸®Æ®
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
  • Áß³²¹Ì
    • ºê¶óÁú
    • ¾Æ¸£ÇîÆ¼³ª
    • ±âŸ Áß³²¹Ì

Á¦12Àå ¾÷°è »óȲ

  • °æÀ念¾ç ½ÃÀåÀÇ ¼ºÀå Àü·«
  • À¯±âÀû ¼ºÀå Àü·«
  • ¹«±âÀû ¼ºÀå Àü·«

Á¦13Àå ±â¾÷ °³¿ä

  • Nestle SA
  • Danone SA
  • Abbott Laboratories
  • Royal FrieslandCampina NV
  • Fresenius SE & Co KGaA
  • B Braun SE
  • Reckitt Benckiser Group Plc
  • Kate Farms Inc
  • Dr Schar AG
  • Fonterra Co-Operative Group Ltd
  • Arla Foods amba
  • Perrigo Co Plc
  • Charing Cross Scientific AS
  • Bexen Medical

Á¦14Àå ºÎ·Ï

ksm

The Enteral Nutrition market was valued at US$ 10.58 billion in 2024 and is projected to reach US$ 17.33 billion by 2031; it is expected to register a CAGR of 7.3% during 2025-2031. Increasing prevalence of gastrointestinal diseases and the rising cases of malnutrition and premature births are contributing to the growing enteral nutrition market size. However, the complications associated with the feeding systems hampers the enteral nutrition market growth. Further, development of plant-based nutrition products is expected to bring in new enteral nutrition market trends in the coming years.

Asia-Pacific region to witness fastest growth rate in the global enteral nutrition market. The Asia Pacific enteral nutrition market is segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. The growth of the market is driven by rising prevalence of chronic diseases and the growing presence of market players across the region, conferring the highest manufacturing of enteral nutrition products. Furthermore, supportive government initiatives and research in the field of nutrition boost market growth. Countries such as Australia, India, and South Korea are estimated to witness various growth opportunities due to the rising development in the healthcare sector. In addition, governments of these countries are increasing their efforts to provide enteral and parenteral nutrition.

In terms of revenue, China dominated the Asia Pacific market in 2024. It is expected to continue its dominance in the global market during the forecast period.

China has experienced a significant rise in the elderly population. Its rapidly aging demographic has led to an increased prevalence of chronic diseases, necessitating nutritional support. According to the 2020 census data, ~264 million were in the age group of 60 and above, and accounted for almost 19% of the Chinese population. The China National Committee on Aging (CNCA) projected that the geriatric population is expected to reach ~487 million by 2050. The increasing prevalence of neurological diseases with the growing elderly population fuels the adoption of enteral nutrition in China. Stroke is the primary cause of death among older people across the country. According to the study published in Elsevier, 17.8 million cases of stroke, 3.4 million new strokes, and 2.3 million stroke-related deaths were reported in the country in 2020. Stroke is the most common cause of acute dysphagia, which may cause malnutrition and impact the quality of life of patients. Tube feeding of critically ill stroke patients is implemented as a nutrition improvement strategy in China.

The increasing number of cancer cases in China also benefits the enteral nutrition market. According to the WHO, ~4.8 million new cancer cases and ~2.5 million deaths due to cancer were reported in China in 2022. Every minute, nearly seven individuals are diagnosed with cancer, and four succumb to the disease. The use of enteral feeding is common in cancer patients undergoing chemotherapy, who often experience difficulty eating due to nausea, mouth sores, or gastrointestinal disturbances..

Enteral Nutrition Market Report Segmentation Analysis

Key segments that contributed to the derivation of the enteral nutrition market analysis are product type, application, age group, and distribution channel.

Based on product type, the enteral nutrition market is categorized into nasogastric, nasoenteral, sipping, and other. The nasogastric segment held the largest share in the enteral nutrition market in 2024.

In terms of application, the enteral nutrition market is segmented into gastrointestinal disorders, renal disease, liver disease, oncology, neurology, and others. The gastrointestinal disorders segment held the largest share in the enteral nutrition market in 2024.

By age group, the enteral nutrition market is bifurcated into adult and pediatric. The adult segment held the largest share in the enteral nutrition market in 2024.

Based on distribution channel, the enteral nutrition market is segmented into hospital pharmacies, retail stores, and e-commerce. The hospital pharmacies segment held the largest share in the enteral nutrition market in 2024

Enteral Nutrition Market: Competitive Landscape and Key Developments

Nestle, Danone S.A., Abbott Laboratories, FrieslandCampina, Fresenius SE and Co. KGaA, B. Braun SE, Dr. Schar AG, Arla Food, Reckitt Benckiser, Perrigo Company PLC, Fonterra Co-operative Group Limited, Kate Farms, Nutritional Medicinals, LLC are among the key companies operating in the enteral nutrition market.

The National Health Service (NHS), British Association for Parenteral and Enteral Nutrition, World Health Organization, US Department of Health and Human Services, Centers for Disease Control and Prevention, British Dietic Association, and National Safety Council are among the primary and secondary sources referred to while preparing the Enteral Nutrition market report.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country level data:

4. Enteral Nutrition Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis

5. Enteral Nutrition Market - Key Market Dynamics

  • 5.1 Enteral Nutrition Market - Key Market Dynamics
  • 5.2 Market Drivers
    • 5.2.1 Increasing Prevalence of Gastrointestinal Diseases
    • 5.2.2 Rising Cases of Malnutrition and Premature Births
  • 5.3 Market Restraints
    • 5.3.1 Complications Associated with the Feeding Systems
  • 5.4 Market Opportunities
    • 5.4.1 Strategic Initiatives by Market Players
  • 5.5 Future Trends
    • 5.5.1 Specific Formulations and Plant-Based Nutrition Products
  • 5.6 Impact of Drivers and Restraints:

6. Enteral Nutrition Market - Global Market Analysis

  • 6.1 Enteral Nutrition Market Revenue (US$ Million), 2021-2031
  • 6.2 Enteral Nutrition Market Forecast Analysis

7. Enteral Nutrition Market Analysis - by Product Type

  • 7.1 Nasogastric
    • 7.1.1 Overview
    • 7.1.2 Nasogastric: Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.2 Nasoenteral
    • 7.2.1 Overview
    • 7.2.2 Nasoenteral: Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.3 Sipping
    • 7.3.1 Overview
    • 7.3.2 Sipping: Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.4 Others
    • 7.4.1 Overview
    • 7.4.2 Others: Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)

8. Enteral Nutrition Market Analysis - by Application

  • 8.1 Gastrointestinal Disorders
    • 8.1.1 Overview
    • 8.1.2 Gastrointestinal Disorders: Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.2 Renal Disease
    • 8.2.1 Overview
    • 8.2.2 Renal Disease: Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.3 Liver Disease
    • 8.3.1 Overview
    • 8.3.2 Liver Disease: Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.4 Oncology
    • 8.4.1 Overview
    • 8.4.2 Oncology: Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.5 Neurology
    • 8.5.1 Overview
    • 8.5.2 Neurology: Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.6 Others
    • 8.6.1 Overview
    • 8.6.2 Others: Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)

9. Enteral Nutrition Market Analysis - by Age Group

  • 9.1 Adult
    • 9.1.1 Overview
    • 9.1.2 Adult: Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.2 Pediatric
    • 9.2.1 Overview
    • 9.2.2 Pediatric: Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)

10. Enteral Nutrition Market Analysis - by Distribution Channel

  • 10.1 Hospital Pharmacies
    • 10.1.1 Overview
    • 10.1.2 Hospital Pharmacies: Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.2 Retail Stores
    • 10.2.1 Overview
    • 10.2.2 Retail Stores: Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.3 E-commerce
    • 10.3.1 Overview
    • 10.3.2 E-commerce: Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)

11. Enteral Nutrition Market - Geographical Analysis

  • 11.1 North America
    • 11.1.1 North America Enteral Nutrition Market Overview
    • 11.1.2 North America: Enteral Nutrition Market - Revenue, 2021 - 2031 (US$ Million)
      • 11.1.2.1 North America: Enteral Nutrition Market- Revenue and Forecast Analysis - by Product Type
        • 11.1.2.1.1 North America: Enteral Nutrition Market- Revenue and Forecast Analysis - by Nasogastric
      • 11.1.2.2 North America: Enteral Nutrition Market- Revenue and Forecast Analysis - by Application
      • 11.1.2.3 North America: Enteral Nutrition Market- Revenue and Forecast Analysis - by Age Group
      • 11.1.2.4 North America: Enteral Nutrition Market- Revenue and Forecast Analysis - by Distribution Channel
    • 11.1.3 North America: Enteral Nutrition Market - Revenue and Forecast Analysis - by Country
      • 11.1.3.1 United States: Enteral Nutrition Market - Revenue, 2021 - 2031 (US$ Million)
        • 11.1.3.1.1 United States: Enteral Nutrition Market Breakdown, by Product Type
        • 11.1.3.1.1.1 United States: Enteral Nutrition Market Breakdown, by Nasogastric
        • 11.1.3.1.2 United States: Enteral Nutrition Market Breakdown, by Application
        • 11.1.3.1.3 United States: Enteral Nutrition Market Breakdown, by Age Group
        • 11.1.3.1.4 United States: Enteral Nutrition Market Breakdown, by Distribution Channel
      • 11.1.3.2 Canada: Enteral Nutrition Market - Revenue, 2021 - 2031 (US$ Million)
        • 11.1.3.2.1 Canada: Enteral Nutrition Market Breakdown, by Product Type
        • 11.1.3.2.1.1 Canada: Enteral Nutrition Market Breakdown, by Nasogastric
        • 11.1.3.2.2 Canada: Enteral Nutrition Market Breakdown, by Application
        • 11.1.3.2.3 Canada: Enteral Nutrition Market Breakdown, by Age Group
        • 11.1.3.2.4 Canada: Enteral Nutrition Market Breakdown, by Distribution Channel
      • 11.1.3.3 Mexico: Enteral Nutrition Market - Revenue, 2021 - 2031 (US$ Million)
        • 11.1.3.3.1 Mexico: Enteral Nutrition Market Breakdown, by Product Type
        • 11.1.3.3.1.1 Mexico: Enteral Nutrition Market Breakdown, by Nasogastric
        • 11.1.3.3.2 Mexico: Enteral Nutrition Market Breakdown, by Application
        • 11.1.3.3.3 Mexico: Enteral Nutrition Market Breakdown, by Age Group
        • 11.1.3.3.4 Mexico: Enteral Nutrition Market Breakdown, by Distribution Channel
  • 11.2 Europe
    • 11.2.1 Europe Enteral Nutrition Market Overview
    • 11.2.2 Europe: Enteral Nutrition Market - Revenue, 2021 - 2031 (US$ Million)
      • 11.2.2.1 Europe: Enteral Nutrition Market- Revenue and Forecast Analysis - by Product Type
        • 11.2.2.1.1 Europe: Enteral Nutrition Market- Revenue and Forecast Analysis - by Nasogastric
      • 11.2.2.2 Europe: Enteral Nutrition Market- Revenue and Forecast Analysis - by Application
      • 11.2.2.3 Europe: Enteral Nutrition Market- Revenue and Forecast Analysis - by Age Group
      • 11.2.2.4 Europe: Enteral Nutrition Market- Revenue and Forecast Analysis - by Distribution Channel
    • 11.2.3 Europe: Enteral Nutrition Market - Revenue and Forecast Analysis - by Country
      • 11.2.3.1 Germany: Enteral Nutrition Market - Revenue, 2021 - 2031 (US$ Million)
        • 11.2.3.1.1 Germany: Enteral Nutrition Market Breakdown, by Product Type
        • 11.2.3.1.1.1 Germany: Enteral Nutrition Market Breakdown, by Nasogastric
        • 11.2.3.1.2 Germany: Enteral Nutrition Market Breakdown, by Application
        • 11.2.3.1.3 Germany: Enteral Nutrition Market Breakdown, by Age Group
        • 11.2.3.1.4 Germany: Enteral Nutrition Market Breakdown, by Distribution Channel
      • 11.2.3.2 United Kingdom: Enteral Nutrition Market - Revenue, 2021 - 2031 (US$ Million)
        • 11.2.3.2.1 United Kingdom: Enteral Nutrition Market Breakdown, by Product Type
        • 11.2.3.2.1.1 United Kingdom: Enteral Nutrition Market Breakdown, by Nasogastric
        • 11.2.3.2.2 United Kingdom: Enteral Nutrition Market Breakdown, by Application
        • 11.2.3.2.3 United Kingdom: Enteral Nutrition Market Breakdown, by Age Group
        • 11.2.3.2.4 United Kingdom: Enteral Nutrition Market Breakdown, by Distribution Channel
      • 11.2.3.3 France: Enteral Nutrition Market - Revenue, 2021 - 2031 (US$ Million)
        • 11.2.3.3.1 France: Enteral Nutrition Market Breakdown, by Product Type
        • 11.2.3.3.1.1 France: Enteral Nutrition Market Breakdown, by Nasogastric
        • 11.2.3.3.2 France: Enteral Nutrition Market Breakdown, by Application
        • 11.2.3.3.3 France: Enteral Nutrition Market Breakdown, by Age Group
        • 11.2.3.3.4 France: Enteral Nutrition Market Breakdown, by Distribution Channel
      • 11.2.3.4 Italy: Enteral Nutrition Market - Revenue, 2021 - 2031 (US$ Million)
        • 11.2.3.4.1 Italy: Enteral Nutrition Market Breakdown, by Product Type
        • 11.2.3.4.1.1 Italy: Enteral Nutrition Market Breakdown, by Nasogastric
        • 11.2.3.4.2 Italy: Enteral Nutrition Market Breakdown, by Application
        • 11.2.3.4.3 Italy: Enteral Nutrition Market Breakdown, by Age Group
        • 11.2.3.4.4 Italy: Enteral Nutrition Market Breakdown, by Distribution Channel
      • 11.2.3.5 Spain: Enteral Nutrition Market - Revenue, 2021 - 2031 (US$ Million)
        • 11.2.3.5.1 Spain: Enteral Nutrition Market Breakdown, by Product Type
        • 11.2.3.5.1.1 Spain: Enteral Nutrition Market Breakdown, by Nasogastric
        • 11.2.3.5.2 Spain: Enteral Nutrition Market Breakdown, by Application
        • 11.2.3.5.3 Spain: Enteral Nutrition Market Breakdown, by Age Group
        • 11.2.3.5.4 Spain: Enteral Nutrition Market Breakdown, by Distribution Channel
      • 11.2.3.6 Czech Republic: Enteral Nutrition Market - Revenue, 2021 - 2031 (US$ Million)
        • 11.2.3.6.1 Czech Republic: Enteral Nutrition Market Breakdown, by Product Type
        • 11.2.3.6.1.1 Czech Republic: Enteral Nutrition Market Breakdown, by Nasogastric
        • 11.2.3.6.2 Czech Republic: Enteral Nutrition Market Breakdown, by Application
        • 11.2.3.6.3 Czech Republic: Enteral Nutrition Market Breakdown, by Age Group
        • 11.2.3.6.4 Czech Republic: Enteral Nutrition Market Breakdown, by Distribution Channel
      • 11.2.3.7 Rest of Europe: Enteral Nutrition Market - Revenue, 2021 - 2031 (US$ Million)
        • 11.2.3.7.1 Rest of Europe: Enteral Nutrition Market Breakdown, by Product Type
        • 11.2.3.7.1.1 Rest of Europe: Enteral Nutrition Market Breakdown, by Nasogastric
        • 11.2.3.7.2 Rest of Europe: Enteral Nutrition Market Breakdown, by Application
        • 11.2.3.7.3 Rest of Europe: Enteral Nutrition Market Breakdown, by Age Group
        • 11.2.3.7.4 Rest of Europe: Enteral Nutrition Market Breakdown, by Distribution Channel
  • 11.3 Asia Pacific
    • 11.3.1 Asia Pacific Enteral Nutrition Market Overview
    • 11.3.2 Asia Pacific: Enteral Nutrition Market - Revenue, 2021 - 2031 (US$ Million)
      • 11.3.2.1 Asia Pacific: Enteral Nutrition Market- Revenue and Forecast Analysis - by Product Type
        • 11.3.2.1.1 Asia Pacific: Enteral Nutrition Market- Revenue and Forecast Analysis - by Nasogastric
      • 11.3.2.2 Asia Pacific: Enteral Nutrition Market- Revenue and Forecast Analysis - by Application
      • 11.3.2.3 Asia Pacific: Enteral Nutrition Market- Revenue and Forecast Analysis - by Age Group
      • 11.3.2.4 Asia Pacific: Enteral Nutrition Market- Revenue and Forecast Analysis - by Distribution Channel
    • 11.3.3 Asia Pacific: Enteral Nutrition Market - Revenue and Forecast Analysis - by Country
      • 11.3.3.1 China: Enteral Nutrition Market - Revenue, 2021 - 2031 (US$ Million)
        • 11.3.3.1.1 China: Enteral Nutrition Market Breakdown, by Product Type
        • 11.3.3.1.1.1 China: Enteral Nutrition Market Breakdown, by Nasogastric
        • 11.3.3.1.2 China: Enteral Nutrition Market Breakdown, by Application
        • 11.3.3.1.3 China: Enteral Nutrition Market Breakdown, by Age Group
        • 11.3.3.1.4 China: Enteral Nutrition Market Breakdown, by Distribution Channel
      • 11.3.3.2 Japan: Enteral Nutrition Market - Revenue, 2021 - 2031 (US$ Million)
        • 11.3.3.2.1 Japan: Enteral Nutrition Market Breakdown, by Product Type
        • 11.3.3.2.1.1 Japan: Enteral Nutrition Market Breakdown, by Nasogastric
        • 11.3.3.2.2 Japan: Enteral Nutrition Market Breakdown, by Application
        • 11.3.3.2.3 Japan: Enteral Nutrition Market Breakdown, by Age Group
        • 11.3.3.2.4 Japan: Enteral Nutrition Market Breakdown, by Distribution Channel
      • 11.3.3.3 India: Enteral Nutrition Market - Revenue, 2021 - 2031 (US$ Million)
        • 11.3.3.3.1 India: Enteral Nutrition Market Breakdown, by Product Type
        • 11.3.3.3.1.1 India: Enteral Nutrition Market Breakdown, by Nasogastric
        • 11.3.3.3.2 India: Enteral Nutrition Market Breakdown, by Application
        • 11.3.3.3.3 India: Enteral Nutrition Market Breakdown, by Age Group
        • 11.3.3.3.4 India: Enteral Nutrition Market Breakdown, by Distribution Channel
      • 11.3.3.4 South Korea: Enteral Nutrition Market - Revenue, 2021 - 2031 (US$ Million)
        • 11.3.3.4.1 South Korea: Enteral Nutrition Market Breakdown, by Product Type
        • 11.3.3.4.1.1 South Korea: Enteral Nutrition Market Breakdown, by Nasogastric
        • 11.3.3.4.2 South Korea: Enteral Nutrition Market Breakdown, by Application
        • 11.3.3.4.3 South Korea: Enteral Nutrition Market Breakdown, by Age Group
        • 11.3.3.4.4 South Korea: Enteral Nutrition Market Breakdown, by Distribution Channel
      • 11.3.3.5 Australia: Enteral Nutrition Market - Revenue, 2021 - 2031 (US$ Million)
        • 11.3.3.5.1 Australia: Enteral Nutrition Market Breakdown, by Product Type
        • 11.3.3.5.1.1 Australia: Enteral Nutrition Market Breakdown, by Nasogastric
        • 11.3.3.5.2 Australia: Enteral Nutrition Market Breakdown, by Application
        • 11.3.3.5.3 Australia: Enteral Nutrition Market Breakdown, by Age Group
        • 11.3.3.5.4 Australia: Enteral Nutrition Market Breakdown, by Distribution Channel
      • 11.3.3.6 Rest of APAC: Enteral Nutrition Market - Revenue, 2021 - 2031 (US$ Million)
        • 11.3.3.6.1 Rest of APAC: Enteral Nutrition Market Breakdown, by Product Type
        • 11.3.3.6.1.1 Rest of APAC: Enteral Nutrition Market Breakdown, by Nasogastric
        • 11.3.3.6.2 Rest of APAC: Enteral Nutrition Market Breakdown, by Application
        • 11.3.3.6.3 Rest of APAC: Enteral Nutrition Market Breakdown, by Age Group
        • 11.3.3.6.4 Rest of APAC: Enteral Nutrition Market Breakdown, by Distribution Channel
  • 11.4 Middle East and Africa
    • 11.4.1 Middle East and Africa Enteral Nutrition Market Overview
    • 11.4.2 Middle East and Africa: Enteral Nutrition Market - Revenue, 2021 - 2031 (US$ Million)
      • 11.4.2.1 Middle East and Africa: Enteral Nutrition Market- Revenue and Forecast Analysis - by Product Type
        • 11.4.2.1.1 Middle East and Africa: Enteral Nutrition Market- Revenue and Forecast Analysis - by Nasogastric
      • 11.4.2.2 Middle East and Africa: Enteral Nutrition Market- Revenue and Forecast Analysis - by Application
      • 11.4.2.3 Middle East and Africa: Enteral Nutrition Market- Revenue and Forecast Analysis - by Age Group
      • 11.4.2.4 Middle East and Africa: Enteral Nutrition Market- Revenue and Forecast Analysis - by Distribution Channel
    • 11.4.3 Middle East and Africa: Enteral Nutrition Market - Revenue and Forecast Analysis - by Country
      • 11.4.3.1 Saudi Arabia: Enteral Nutrition Market - Revenue, 2021 - 2031 (US$ Million)
        • 11.4.3.1.1 Saudi Arabia: Enteral Nutrition Market Breakdown, by Product Type
        • 11.4.3.1.1.1 Saudi Arabia: Enteral Nutrition Market Breakdown, by Nasogastric
        • 11.4.3.1.2 Saudi Arabia: Enteral Nutrition Market Breakdown, by Application
        • 11.4.3.1.3 Saudi Arabia: Enteral Nutrition Market Breakdown, by Age Group
        • 11.4.3.1.4 Saudi Arabia: Enteral Nutrition Market Breakdown, by Distribution Channel
      • 11.4.3.2 South Africa: Enteral Nutrition Market - Revenue, 2021 - 2031 (US$ Million)
        • 11.4.3.2.1 South Africa: Enteral Nutrition Market Breakdown, by Product Type
        • 11.4.3.2.1.1 South Africa: Enteral Nutrition Market Breakdown, by Nasogastric
        • 11.4.3.2.2 South Africa: Enteral Nutrition Market Breakdown, by Application
        • 11.4.3.2.3 South Africa: Enteral Nutrition Market Breakdown, by Age Group
        • 11.4.3.2.4 South Africa: Enteral Nutrition Market Breakdown, by Distribution Channel
      • 11.4.3.3 United Arab Emirates: Enteral Nutrition Market - Revenue, 2021 - 2031 (US$ Million)
        • 11.4.3.3.1 United Arab Emirates: Enteral Nutrition Market Breakdown, by Product Type
        • 11.4.3.3.1.1 United Arab Emirates: Enteral Nutrition Market Breakdown, by Nasogastric
        • 11.4.3.3.2 United Arab Emirates: Enteral Nutrition Market Breakdown, by Application
        • 11.4.3.3.3 United Arab Emirates: Enteral Nutrition Market Breakdown, by Age Group
        • 11.4.3.3.4 United Arab Emirates: Enteral Nutrition Market Breakdown, by Distribution Channel
      • 11.4.3.4 Rest of Middle East and Africa: Enteral Nutrition Market - Revenue, 2021 - 2031 (US$ Million)
        • 11.4.3.4.1 Rest of Middle East and Africa: Enteral Nutrition Market Breakdown, by Product Type
        • 11.4.3.4.1.1 Rest of Middle East and Africa: Enteral Nutrition Market Breakdown, by Nasogastric
        • 11.4.3.4.2 Rest of Middle East and Africa: Enteral Nutrition Market Breakdown, by Application
        • 11.4.3.4.3 Rest of Middle East and Africa: Enteral Nutrition Market Breakdown, by Age Group
        • 11.4.3.4.4 Rest of Middle East and Africa: Enteral Nutrition Market Breakdown, by Distribution Channel
  • 11.5 South and Central America
    • 11.5.1 South and Central America Enteral Nutrition Market Overview
    • 11.5.2 South and Central America: Enteral Nutrition Market - Revenue, 2021 - 2031 (US$ Million)
      • 11.5.2.1 South and Central America: Enteral Nutrition Market- Revenue and Forecast Analysis - by Product Type
        • 11.5.2.1.1 South and Central America: Enteral Nutrition Market- Revenue and Forecast Analysis - by Nasogastric
      • 11.5.2.2 South and Central America: Enteral Nutrition Market- Revenue and Forecast Analysis - by Application
      • 11.5.2.3 South and Central America: Enteral Nutrition Market- Revenue and Forecast Analysis - by Age Group
      • 11.5.2.4 South and Central America: Enteral Nutrition Market- Revenue and Forecast Analysis - by Distribution Channel
    • 11.5.3 South and Central America: Enteral Nutrition Market - Revenue and Forecast Analysis - by Country
      • 11.5.3.1 Brazil: Enteral Nutrition Market - Revenue, 2021 - 2031 (US$ Million)
        • 11.5.3.1.1 Brazil: Enteral Nutrition Market Breakdown, by Product Type
        • 11.5.3.1.1.1 Brazil: Enteral Nutrition Market Breakdown, by Nasogastric
        • 11.5.3.1.2 Brazil: Enteral Nutrition Market Breakdown, by Application
        • 11.5.3.1.3 Brazil: Enteral Nutrition Market Breakdown, by Age Group
        • 11.5.3.1.4 Brazil: Enteral Nutrition Market Breakdown, by Distribution Channel
      • 11.5.3.2 Argentina: Enteral Nutrition Market - Revenue, 2021 - 2031 (US$ Million)
        • 11.5.3.2.1 Argentina: Enteral Nutrition Market Breakdown, by Product Type
        • 11.5.3.2.1.1 Argentina: Enteral Nutrition Market Breakdown, by Nasogastric
        • 11.5.3.2.2 Argentina: Enteral Nutrition Market Breakdown, by Application
        • 11.5.3.2.3 Argentina: Enteral Nutrition Market Breakdown, by Age Group
        • 11.5.3.2.4 Argentina: Enteral Nutrition Market Breakdown, by Distribution Channel
      • 11.5.3.3 Rest of South and Central America: Enteral Nutrition Market - Revenue, 2021 - 2031 (US$ Million)
        • 11.5.3.3.1 Rest of South and Central America: Enteral Nutrition Market Breakdown, by Product Type
        • 11.5.3.3.1.1 Rest of South and Central America: Enteral Nutrition Market Breakdown, by Nasogastric
        • 11.5.3.3.2 Rest of South and Central America: Enteral Nutrition Market Breakdown, by Application
        • 11.5.3.3.3 Rest of South and Central America: Enteral Nutrition Market Breakdown, by Age Group
        • 11.5.3.3.4 Rest of South and Central America: Enteral Nutrition Market Breakdown, by Distribution Channel

12. Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies in Enteral Nutrition Market
  • 12.3 Organic Growth Strategies
    • 12.3.1 Overview
  • 12.4 Inorganic Growth Strategies
    • 12.4.1 Overview

13. Company Profiles

  • 13.1 Nestle SA
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Danone SA
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Abbott Laboratories
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Royal FrieslandCampina NV
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Fresenius SE & Co KGaA
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 B Braun SE
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Reckitt Benckiser Group Plc
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 Kate Farms Inc
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 Dr Schar AG
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 Fonterra Co-Operative Group Ltd
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments
  • 13.11 Arla Foods amba
    • 13.11.1 Key Facts
    • 13.11.2 Business Description
    • 13.11.3 Products and Services
    • 13.11.4 Financial Overview
    • 13.11.5 SWOT Analysis
    • 13.11.6 Key Developments
  • 13.12 Perrigo Co Plc
    • 13.12.1 Key Facts
    • 13.12.2 Business Description
    • 13.12.3 Products and Services
    • 13.12.4 Financial Overview
    • 13.12.5 SWOT Analysis
    • 13.12.6 Key Developments
  • 13.13 Charing Cross Scientific AS
    • 13.13.1 Key Facts
    • 13.13.2 Business Description
    • 13.13.3 Products and Services
    • 13.13.4 Financial Overview
    • 13.13.5 SWOT Analysis
    • 13.13.6 Key Developments
  • 13.14 Bexen Medical
    • 13.14.1 Key Facts
    • 13.14.2 Business Description
    • 13.14.3 Products and Services
    • 13.14.4 Financial Overview
    • 13.14.5 SWOT Analysis
    • 13.14.6 Key Developments

14. Appendix

  • 14.1 About The Insight Partners
  • 14.2 Glossary of Terms
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦